JP Morgan Chase’s Covisint Corporation COVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-9,027
Closed -$17K 5375
2016
Q4
$17K Hold
9,027
﹤0.01% 4733
2016
Q3
$20K Hold
9,027
﹤0.01% 4197
2016
Q2
$20K Hold
9,027
﹤0.01% 4232
2016
Q1
$18K Buy
9,027
+8,721
+2,850% +$17.7K ﹤0.01% 4117
2015
Q4
$1K Buy
+306
New +$693 ﹤0.01% 4652
2015
Q3
Sell
-18,883
Closed -$62K 4219
2015
Q2
$62K Sell
18,883
-347,284
-95% -$823K ﹤0.01% 3906
2015
Q1
$744K Buy
366,167
+9,664
+3% +$22.5K ﹤0.01% 3353
2014
Q4
$945K Buy
+356,503
New +$1.02M ﹤0.01% 3378

Other funds holding COVS

JP Morgan Chase's COVS Position: Q1 2017 in Review

JP Morgan Chase sold out of Covisint Corporation (COVS) in Q1 2017, closing a stake of 9,027 shares — an estimated $17K sold.

JP Morgan Chase first reported a position in COVS in Q4 2014 and held it in 8 quarters. The position peaked at $945K in Q4 2014. 57 funds tracked by Wall St. Rank hold COVS as of Q1 2017.

  • JP Morgan Chase reported no remaining Covisint Corporation position as of Q1 2017 after selling out during the quarter.
  • JP Morgan Chase sold 9,027 Covisint Corporation shares in Q1 2017, an estimated $17K.
  • JP Morgan Chase first reported a position in Covisint Corporation in Q4 2014 and held it in 8 quarters.
  • JP Morgan Chase's Covisint Corporation position peaked at $945K in Q4 2014.
  • 57 funds tracked by Wall St. Rank held Covisint Corporation as of Q1 2017.

Based on JP Morgan Chase's 13F filing for Q1 2017, filed 10 May 2017.